Li Nan (LN) (CIK 2131608) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-11). Recent activity: Buy ODTX (1.7M shares), Buy ODTX (1.1M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-11 | Odyssey Therapeutics, Inc. (ODTX) | Director | Buy | 1.7M | $0 |
| 2026-05-11 | Odyssey Therapeutics, Inc. (ODTX) | Director | Buy | 1.1M | $20.0M |
Source: SEC Form 4 filings · as of 2026-05-11